Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks

The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market.According to a Goldman Sachs analysis, earlier last year, the global industry for anti-obesity medications (AOMs) reached $6 billion on an annualized basis. By 2030, the sector could expand by more than 16 times to$100 billion.One of the main reasons why top weight-loss stocks have been performing well is the intersection between the underlying solutions and therapeutics addressing issues suc ...